OClawVPS.com
Torrent Pharmaceuticals Ltd
Edit

Torrent Pharmaceuticals Ltd

http://www.torrentpharma.com/
Last activity: 04.04.2026
Active
Categories: AcquisitionHealthcareIndiaManufacturingPharmaceuticals
Torrent Pharma, with a market cap of over Rs. 20,000 Cr, is a flagship company of the Torrent Group. It is ranked among the top Pharma Companies of India with many of its products ranking among the top 500 brands (AIOCD Dataset). It is a dominant player in the therapeutic areas of Cardiovascular (CV) and Central Nervous System (CNS) and has achieved significant presence in Gastro-intestinal, Diabetology, Anti-infective and Pain Management segments. It has also forayed into the Oncology and Nephrology segments while also strengthening its focus on Gynaecology and Nutraceuticals segments. Torrent Pharma’s competitive advantage stems from its world-class manufacturing facilities located at Indrad and Dahej in Gujarat, Baddi in Himachal Pradesh and Sikkim in North East, advanced R&D capabilities, extensive domestic network and a widespread global presence across 40 countries. The plants are approved by authorities from various regulated and semi regulated markets like US, UK, Brazil, Germany, Australia and South Africa. Right from pioneering niche marketing in India to earning the sobriquet of ‘the Company with the most First Launches’, Torrent Pharma has always remained ahead of its competition.
Likes
46.39K
Followers
177.55K
Website visits
60.5K /mo.
Mentions
39
Location: India
Employees: 10001+
Phone: +91 79 2659 9000
Total raised: $40M
Founded date: 1971

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
02.04.2014-$40M-

Mentions in press and media 39

DateTitleDescription
04.04.2026India’s pharma exports grow 5.6% to $28 billion in April–February FY26-
20.02.2026ChrysCapital inks $159 mn control deal for Novartis India, makes open offerThe Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann Homegrown private equity firm ChrysCapital has agreed to acquire Swiss pharmaceutical major Novartis AG’s entire stake in its Mumbai-listed unit for Rs...
13.02.2026Q3 Results Today Highlights: NBCC (India), IPCA Lab, NLC Industries Q3 profit up, Alkem Lab shares slump, Rategain & Blue Jet profit fallData Analysis. Pen with business report on financial advisor desk. Concept of business planning , accounting, business analysis,financial planning services. istock photo for BL | Photo Credit: utah778 Q3 Results Today, 13th Feb 2026 Highlig...
21.01.2026Torrent Pharma recognised as new promoter of JB Chemicals; CEO to step down-
08.01.2026Torrent Pharma lines up mega ₹12,500 crore acquisition-funding bond sale-
28.11.2025GST authority imposes ₹41 cr penalty on Torrent Pharmaceuticals-
20.11.2025Databricks Eyes $130 Billion Valuation in New Funding RoundDatabricks is reportedly seeking fresh capital. A new funding round could value the company at over $130 billion. This is a significant jump from its previous $100 billion valuation. The AI-focused data platform continues its rapid growth. ...
18.11.2025Databricks in talks to raise capital at above $130 billion valuation: The InformationSynopsis Databricks is reportedly discussing a new funding round that could value the company at over $130 billion, far above its previous $100 billion valuation. The AI-focused data platform, which recently raised $1 billion, continues to ...
07.11.2025Torrent Pharma report 30.5% rise in net profit for Q2 FY26-
22.10.2025Torrent Pharma gets CCI nod to acquire majority stake in KKR-backed JB Chemicals — Details here-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In